Fig. 4From: EphA2-specific microvesicles derived from tumor cells facilitate the targeted delivery of chemotherapeutic drugs for osteosarcoma therapyTargeting capability of YSA-SPION-MV in vivo. A Fluorescence distribution in tumor-bearing mice after tail vein injection of free Dir, YSA-SPION-MV/Dir or YSA-SPION-MV/Dir. B Fluorescence imaging of excised organs from tumor-bearing mice 10 h after tail vein injection of free Dir, YSA-SPION-MV/Dir or YSA-SPION-MV/DirBack to article page